Imagine a glucose meter for diabetes, but for heart failure. Instead of going to a hospital for expensive blood tests, a patient just pricks their finger to check four critical health markers at once. It gives doctors the answers they need in under ten minutes to adjust medication right at home.
Heart failure management currently relies on infrequent, expensive hospital tests, leading to delayed treatment and avoidable readmissions.
A handheld POC reader and disposable strips capable of measuring potassium, sodium, creatinine, and NT-proBNP from a single drop of blood.
If you are a device manufacturer dealing with the lack of decentralized heart failure tools — this project developed a handheld reader and disposable strips that measure four biomarkers simultaneously. This allows for a shift from hospital-based testing to home-care settings.
If you are a care center operator dealing with high hospital readmission rates — this project developed a POC device that provides results in under ten minutes. This enables prompt treatment adjustments to prevent acute decompensation events.
If you are a pharma company dealing with adverse side effects like kidney failure in patients — this project developed a way to monitor creatinine and electrolytes via finger-prick. This helps clinicians optimize drug dosage based on real-time data.
Based on available project data, specific pricing is not mentioned, but the objective is to create an affordable alternative to expensive hospital-based testing.
Yes, the project objective explicitly includes developing a scalable point-of-care diagnostic device for decentralized monitoring.
The device is built on proprietary sensor technology, though specific licensing terms are not detailed in the project summary.
The project objective is to validate and prepare the device for regulatory approval to ensure it meets clinical standards.
It is designed as a handheld device for use in home-care, pharmacies, and clinics, supported by a connected data infrastructure.
The project is led by a single French SME, OMINI, which holds a 100% industry ratio. This lean structure suggests a highly focused commercial drive, as the entire EU contribution of EUR 2,499,999 is directed toward a single industrial entity to accelerate the path to market.
Contact OMINI in France for partnership opportunities regarding POC diagnostics.
Contact us to explore licensing opportunities for this multiplex sensor technology.
